Scott Demarest

2.3k total citations
53 papers, 1.0k citations indexed

About

Scott Demarest is a scholar working on Genetics, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Scott Demarest has authored 53 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Genetics, 21 papers in Psychiatry and Mental health and 14 papers in Molecular Biology. Recurrent topics in Scott Demarest's work include Genetics and Neurodevelopmental Disorders (38 papers), Epilepsy research and treatment (19 papers) and Genomic variations and chromosomal abnormalities (13 papers). Scott Demarest is often cited by papers focused on Genetics and Neurodevelopmental Disorders (38 papers), Epilepsy research and treatment (19 papers) and Genomic variations and chromosomal abnormalities (13 papers). Scott Demarest collaborates with scholars based in United States, Australia and United Kingdom. Scott Demarest's co-authors include Tim A. Benke, Helen Leonard, Heather E. Olson, Jenny Downs, Lindsay C. Swanson, Elia Pestana‐Knight, Dennis Lal, Sumit Parikh, Amy R. Brooks‐Kayal and J. Helen Cross and has published in prestigious journals such as Nature Communications, Neurology and The Lancet Neurology.

In The Last Decade

Scott Demarest

48 papers receiving 992 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott Demarest United States 17 614 387 346 144 125 53 1.0k
Amy McTague United Kingdom 16 653 1.1× 344 0.9× 640 1.8× 275 1.9× 223 1.8× 32 1.2k
Giulia Barcia France 17 501 0.8× 583 1.5× 539 1.6× 221 1.5× 292 2.3× 56 1.3k
Costin Leu United States 14 459 0.7× 257 0.7× 250 0.7× 63 0.4× 100 0.8× 35 769
Bruria Ben Zeev Israel 19 461 0.8× 371 1.0× 349 1.0× 189 1.3× 258 2.1× 47 1.1k
Zaid Afawi Israel 17 441 0.7× 442 1.1× 449 1.3× 90 0.6× 266 2.1× 27 1.1k
Xiu‐Yu Shi China 15 234 0.4× 283 0.7× 369 1.1× 143 1.0× 219 1.8× 57 731
Bobby P.C. Koeleman Netherlands 23 547 0.9× 482 1.2× 819 2.4× 315 2.2× 368 2.9× 48 1.4k
Eduardo Pérez‐Palma United States 16 478 0.8× 500 1.3× 195 0.6× 39 0.3× 154 1.2× 38 888
Lucio Parmeggiani Italy 18 255 0.4× 241 0.6× 641 1.9× 321 2.2× 274 2.2× 44 1.0k
Keming Xu China 12 166 0.3× 355 0.9× 274 0.8× 79 0.5× 307 2.5× 29 621

Countries citing papers authored by Scott Demarest

Since Specialization
Citations

This map shows the geographic impact of Scott Demarest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Demarest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Demarest more than expected).

Fields of papers citing papers by Scott Demarest

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Demarest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Demarest. The network helps show where Scott Demarest may publish in the future.

Co-authorship network of co-authors of Scott Demarest

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Demarest. A scholar is included among the top collaborators of Scott Demarest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Demarest. Scott Demarest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leonard, Helen, Eric D. Marsh, Scott Demarest, et al.. (2025). Content Validation of the Communication Inventory Disability–Observer Reported (CID-OR). Journal of Child Neurology. 41(4). 520–528.
2.
3.
Gleeson, Joseph G., Laurence Mignon, Winston X. Yan, et al.. (2024). A framework for N-of-1 trials of individualized gene-targeted therapies for genetic diseases. Nature Communications. 15(1). 9802–9802. 7 indexed citations
4.
Demarest, Scott, Peter Jacoby, Heather E. Olson, et al.. (2024). Modification of a parent-report sleep scale for individuals with CDKL5 deficiency disorder: a psychometric study. Journal of Clinical Sleep Medicine. 20(12). 1887–1893. 1 indexed citations
5.
Demarest, Scott, et al.. (2024). Chromosome 8p Syndromes Clinical Presentation and Management Guidelines. Clinical Genetics. 107(2). 169–178.
6.
Reed, Laurel, et al.. (2023). Epilepsy panels in clinical practice: Yield, variants of uncertain significance, and treatment implications. Epilepsy Research. 193. 107167–107167. 1 indexed citations
7.
Olson, Heather E., Sam Amin, Nadia Bahi‐Buisson, et al.. (2023). Long‐term treatment with ganaxolone for seizures associated with cyclin‐dependent kinase‐like 5 deficiency disorder: Two‐year open‐label extension follow‐up. Epilepsia. 65(1). 37–45. 16 indexed citations
8.
Lee, MinJae, Wendy K. Chung, Scott Demarest, et al.. (2023). Patterns of developmental regression and associated clinical characteristics in SLC6A1-related disorder. Frontiers in Neuroscience. 17. 1024388–1024388. 8 indexed citations
9.
Leonard, Helen, Peter Jacoby, Eric D. Marsh, et al.. (2023). Validating the Communication and Symbolic Behavior Scales–Developmental Profile Infant–Toddler Checklist (CSBS–DP ITC) Beyond Infancy in the CDKL5 Deficiency Disorder. Journal of Autism and Developmental Disorders. 54(7). 2526–2535. 6 indexed citations
10.
11.
Knowles, Juliet K., Ingo Helbig, Cameron S. Metcalf, et al.. (2022). Precision medicine for genetic epilepsy on the horizon: Recent advances, present challenges, and suggestions for continued progress. Epilepsia. 63(10). 2461–2475. 65 indexed citations
12.
Pestana‐Knight, Elia, et al.. (2022). CDKL5 Deficiency Disorder-Related Epilepsy: A Review of Current and Emerging Treatment. CNS Drugs. 36(6). 591–604. 19 indexed citations
13.
Nelson, Julie A., et al.. (2021). Evolution of Infantile Spasms to Lennox-Gastaut Syndrome: What Is There to Know?. Journal of Child Neurology. 36(9). 752–759. 14 indexed citations
14.
Olson, Heather E., Lindsay C. Swanson, Scott Demarest, et al.. (2021). Current neurologic treatment and emerging therapies in CDKL5 deficiency disorder. Journal of Neurodevelopmental Disorders. 13(1). 40–40. 32 indexed citations
15.
Demarest, Scott, et al.. (2021). Clinical Trial Design for Disease-Modifying Therapies for Genetic Epilepsies. Neurotherapeutics. 18(3). 1445–1457. 7 indexed citations
16.
Wong, Kingsley, et al.. (2020). Exploring genotype‐phenotype relationships in the CDKL5 deficiency disorder using an international dataset. Clinical Genetics. 99(1). 157–165. 25 indexed citations
17.
Joshi, Charuta, Katherine Nickels, Scott Demarest, et al.. (2020). Results of an international Delphi consensus in epilepsy with myoclonic atonic seizures/ Doose syndrome. Seizure. 85. 12–18. 16 indexed citations
18.
Arystarkhova, Elena, Ihtsham Haq, Fanny Mochel, et al.. (2019). Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competition. Neurobiology of Disease. 132. 104577–104577. 28 indexed citations
19.
Olson, Heather E., Scott Demarest, Elia Pestana‐Knight, et al.. (2019). Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Clinical Review. Pediatric Neurology. 97. 18–25. 150 indexed citations
20.
Eschbach, Krista, Angela Moss, Charuta Joshi, et al.. (2018). Diagnosis switching and outcomes in a cohort of patients with potential epilepsy with myoclonic-atonic seizures. Epilepsy Research. 147. 95–101. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amy McTague Breakdown of academic impact, for papers by Giulia Barcia Breakdown of academic impact, for papers by Costin Leu Breakdown of academic impact, for papers by Bruria Ben Zeev Breakdown of academic impact, for papers by Zaid Afawi Breakdown of academic impact, for papers by Xiu‐Yu Shi Breakdown of academic impact, for papers by Bobby P.C. Koeleman Breakdown of academic impact, for papers by Eduardo Pérez‐Palma Breakdown of academic impact, for papers by Lucio Parmeggiani Breakdown of academic impact, for papers by Keming Xu
Rankless by CCL
2026